(NYSEMKT: INFU) Infusystem Holdings's forecast annual revenue growth rate of 3.12% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Infusystem Holdings's revenue in 2026 is $143,335,000.On average, 5 Wall Street analysts forecast INFU's revenue for 2026 to be $2,948,937,819, with the lowest INFU revenue forecast at $2,822,463,720, and the highest INFU revenue forecast at $3,044,341,116. On average, 7 Wall Street analysts forecast INFU's revenue for 2027 to be $3,163,844,202, with the lowest INFU revenue forecast at $3,000,124,974, and the highest INFU revenue forecast at $3,356,642,514.
In 2027, INFU is forecast to generate $3,130,781,681 in revenue, with the lowest revenue forecast at $2,978,614,419 and the highest revenue forecast at $3,246,102,159.